The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lefebvre Eric since 2020.
This trader's CIK number is 1614741.
At the time of last reporting, Lefebvre Eric was the Chief Medical Officer of Pliant Therapeutics, Inc.. (stock ticker symbol PLRX).
Also see all insider trading activities at Pliant Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PLRX | 0 | $0 | 18,478 | $206,972 | 0 | $0 |
2024 | PLRX | 0 | $0 | 22,614 | $319,789 | 0 | $0 |
2023 | PLRX | 0 | $0 | 101,066 | $3,027,808 | 0 | $0 |
2022 | PLRX | 0 | $0 | 18,887 | $393,202 | 0 | $0 |
2021 | PLRX | 0 | $0 | 12,500 | $494,737 | 0 | $0 |
2020 | PLRX | 0 | $0 | 12,500 | $332,187 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-01-17 | PLRX | Sale | 18,478 | 11.20 | 206,972 |
2024-07-10 | PLRX | Sale | 12,319 | 11.56 | 142,407 |
2024-01-17 | PLRX | Sale | 10,295 | 17.23 | 177,382 |
2023-07-17 | PLRX | Sale | 22,321 | 18.01 | 401,978 |
2023-03-30 | PLRX | Sale | 11,245 | 26.52 | 298,228 |
2023-01-23 | PLRX | Sale | 67,500 | 34.48 | 2,327,602 |
2022-12-20 | PLRX | Sale | 10,887 | 19.10 | 207,963 |
2022-10-25 | PLRX | Sale | 5,000 | 25.05 | 125,239 |
2022-07-11 | PLRX | Sale | 3,000 | 20.00 | 60,000 |
2021-03-18 | PLRX | Sale | 12,500 | 39.58 | 494,737 |
2020-12-18 | PLRX | Sale | 12,500 | 26.57 | 332,187 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lefebvre Eric (Chief Medical Officer of Pliant Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.